Picture of Orion Oyj logo

ORNBV Orion Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Orion Terminates Odm-111 Development Program Due To Narrow Therapeutic Window Of The Molecule

Oct 24 (Reuters) - Orion Oyj  ORNBV.HE :
    * INSIDE INFORMATION: ORION TERMINATES ODM-111 DEVELOPMENT
PROGRAM
DUE TO NARROW THERAPEUTIC WINDOW OF THE MOLECULE
    * ORION OYJ - ODM-111 MOLECULE PROFILE DOES NOT SUPPORT
LONG-TERM
USE
    * ORION OYJ - PHASE I TRIALS SHOW NO SIGNIFICANT SAFETY
CONCERNS
FOR ODM-111

Source text for Eikon:  ID:nGNE5WscFV 
Further company coverage:  ORNBV.HE 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Orion Oyj

See all news